4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-026618
EVP and CCO sold 1,501 shares at $49.21 ($73,864)
- EVP and CCO acquired 4,206 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YANG MICHAEL J. EVP and CCO | 2020-04-29 | Option exercise | +4,206 | 6,705 | D | ||
| YANG MICHAEL J. EVP and CCO | 2020-04-30 | Sale | −1,501 | $49.21 | $73,864 | 5,204 | D |
| Derivatives | |||||||
| YANG MICHAEL J. EVP and CCO | 2020-04-29 | Option exercise · Restricted Stock Units | −4,206 | 12,621 | D | ||
| Open-market sales · 1,501 sh · avg $49.21 · $73,864 | |||||||
Loading xslF345X03/doc4.xml…